Skip to main content

Table 1 The expression of FSHR, CD34, and D2-40 in peritumoral vessels associated with invasive breast cancer

From: Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery

   Marker immunostained vessels/mm 2 a p-value
Tumors No of cases FSHR CD34 D2-40 FSHR vs. CD34 FSHR vs. D2-40 CD34 vs. D2-40
HR+/HER2- 35 36.7 ± 4.0 100.4 ± 26 3.9 ± 3.7 p < 0.001 p > 0.05 p < 0.01
HR+/HER2+ 13 31.4 ± 5.2 92.4 ± 13.9 5.4 ± 4.7 p < 0.001 p > 0.05 p = 0.01
HR-/HER2+ 19 39.6 ± 6.0 84.3 ± 28.3 5.7 ± 1.9 p < 0.001 p > 0.05 p = 0.01
TN 16 38.4 ± 8.0 106.8 ± 13.4 7.9 ± 2.8 p < 0.001 p > 0.05 p < 0.01
  1. aAverage ± standard error.